Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV003026925 | SCV003328456 | likely benign | not provided | 2023-11-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003026926 | SCV003615377 | likely benign | Inborn genetic diseases | 2022-05-02 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003026925 | SCV004147265 | uncertain significance | not provided | 2023-06-01 | criteria provided, single submitter | clinical testing | LRP2: PM2, BP4 |